Weighted Average Number of Shares Outstanding, Basic of Ambrx Biopharma Cayman, Inc. from 2021 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Ambrx Biopharma Cayman, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from 2021 to Q2 2023.
  • Ambrx Biopharma Cayman, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2023 was 391M shares, a 44.8% increase year-over-year.
  • Ambrx Biopharma Cayman, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 270M shares, a 88.7% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Ambrx Biopharma Cayman, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 391M +121M +44.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 315M +44.8M +16.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q2 2022 270M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 270M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11

Ambrx Biopharma Cayman, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 270M +127M +88.7% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-30
2021 143M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.